BECN2 and metastatic malignant neoplasm in the lymph nodes: We found that negativity of Beclin 1 was associated with poor recurrence free survival, yet positivity of Beclin 2 was linked to poor prognostic factors, including positive lymphovascular status and lymph node metastasis.